Health Canada Issues Warning for Antibiotic Rofact (Rifampin)
A Small Number of Bottles Contain the Wrong Drug
Health Canada is warning consumers that there is a small possibility that some bottles of one lot of Rofact® (rifampin), an antibiotic used to treat tuberculosis (TB) and some other infections, may contain the drug clonazepam instead of the antibiotic rifampin.
The affected lot number of Rofact® is 8K5467, and the Drug Identification Number (DIN) is 00343617. Clonazepam is an anti-epileptic medication and has sedating properties. The manufacturer, Valeant Canada, is initiating a recall to the retail level.
Consumers who have Rofact® (rifampin) at home are advised to check their bottle of medication and confirm that they have the correct, prescribed drug.
The bottles in question are for Rofact® 300 mg, and were erroneously filled with clonazepam 0.5 mg. Rofact® (rifampin) is an antibiotic used to treat tuberculosis (TB) and some other infections. Rofact® 300 mg are hard capsules, brown and dark red in colour, and marked ‘ICN R12' while the clonazepam pills are orange, round tablets and are marked ‘c31' and ‘0.5'.
The side-effects associated with the use of products containing clonazepam vary according to the individual and can include dizziness, drowsiness, muscle weakness, confusion, and loss of memory. Due to the potential for impairment of mental alertness or physical coordination, patients exposed to clonazepam may be at risk of accidents when operating machinery or driving a motor vehicle.
The bottles were mislabelled due to a production error, and it is believed that a maximum of 4 bottles were filled incorrectly at the factory. One was discovered by a pharmacist before any medication was dispensed to a consumer, therefore at most 3 bottles may be on the Canadian market. Prescriptions of Rofact® may be dispensed from a pharmacy in smaller amounts and not in the original bottle. The incorrectly labelled bottles of Rofact® may have been on the Canadian market since December 2008.
MAY-15-09: Bottles of the Antibiotic Rofact® (Rifampin) May Contain a Different Drug[HEALTH CANADA: SMALL NUMBER OF RIFAMPIN BOTTLES MAY CONTAIN WRONG DRUG]
Legal Help
If you or a loved one has suffered adverse health effects as a result of this circumstance, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Related Law Suits
Health Canada Issues Warning Law Suit and Settlement
FDA Issues Warning about Promethazine Hydrochloride Injection Law Suit and Settlement
FDA Issues Warning Regarding Topical Ibuprofen Drug Products Law Suit and Settlement
FDA Issues Safety Warning About Valproic Acid and Divalproex Sodium Law Suit and Settlement
FFDA Issues Warning about Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution Law Suit and Settlement
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory Law Suit and Settlement
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes Law Suit and Settlement
FDA Issues Update on Safety Review Orlistat Law Suit and Settlement
FDA Issues Early Safety Communication About Meridia Diet Pill Law Suit and Settlement
Donjoy Inc. and DJ Ortho, Canada Inc. Law Suit and Settlement
See more stories from this source.
Class Action Law Suits
Newsworthy Law Suits
Defective Products Lawsuits
Discrimination Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Insurance Lawsuits
Malpractice Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits
Related Law Articles
is===1Related Law Questions
Related Law Bulletins
Lawyers! Become an Approved Expert to Answer Questions.
Apply Now!
You'll get lots of targetted traffic to your website and new client leads!
is===1
